MASH
The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.
Higher Risk of Serious Infection in Offspring of Mothers With Biopsy-Proven MASLD: A Nationwide Cohort Study.
Marxer Carole A (CA);Ebrahimi Fahim (F);Bergman David (D);Sun Jiangwei (J);Hagström Hannes (H);Thuresson Marcus (M);Stephansson Olof (O);Ludvigsson Jonas F (JF)
Risk of Extrahepatic Cancer for Metabolic Dysfunction-Associated Steatohepatitis (MASH) in the United States Medicare Population.
Kim Yestle (Y);Nunag Dominic (D);Davis Matthew (M);Gish Robert (R)
Unveiling the Burden of Steatotic Liver Disease: Mortality Risks by Subtype and Fibrosis Stage in a Nationwide Cohort.
Feng Qi (Q);Manousou Pinelopi (P);Izzi-Engbeaya Chioma N (CN);Loomba Rohit (R);Thursz Mark (M);Woodward Mark (M)
SGLT-2 Inhibitors Are Associated With Lower Mortality and Decompensation in Patients With MASH Cirrhosis and Type 2 Diabetes.
Kim Do Han (DH);Ko Donghyun (D);Chen Vincent L (VL);Porres Jose A (JA);Elizondo Alatorre Carlos (C);Nieto Luis M (LM);Palacios Argueta Pedro (P);Kröner Paul T (PT);Lukens Frank J (FJ);Kim Donghee (D);Karagozian Raffi (R);Bansal Meena B (MB);Wijarnpreecha Karn (K)
Mortality and Causes of Death After Metabolic Bariatric Surgery in Older Patients.
Gerber Peter (P);Santoni Giola (G);von Euler-Chelpin My (M);H Kauppila Joonas (J);Holmberg Dag (D)
Impact of Type 2 Diabetes Mellitus on Liver Fibrosis and Hepatic Steatosis in Patients with Primary Biliary Cholangitis: A Longitudinal Study.
Williams Elizabeth E (EE);Lammert Craig (C);Vuppalanchi Raj (R)
Liverrisk score (LRS) predicts long-term liver-related outcomes in a cohort of veterans without evidence of liver disease.
Hernaez Ruben (R);Liu Yan (Y);Serra-Burriel Miquel (M);Patidar Kavish R (KR);Juanola Adrià (A);Graupera Isabel (I);Pose Elisa (E);Fabrellas Núria (N);Flores Avegail G (AG);Kramer Jennifer R (JR);Kanwal Fasiha (F);Gines Pere (P)
The contested association between MASLD and osteoporosis: a narrative review of heterogeneous evidence and modifying factors.
Xiao Ya-Jun (YJ);Zhang Yan-Ling (YL);Mao Xiao-Zhou (XZ);Yang Di (D);Liu Yan-Qun (YQ);Yan Cheng ();Liu Xiao-Ling (XL);Sun Chang-Feng (CF);Sun Hao (H);Deng Cun-Liang (CL)
Letter to the Editor regarding: 'Global epidemiology of diabetes and prediabetes in lean or non-obese patients with NAFLD: a systematic review and meta-analysis'.
Ruan Chenglu (C);Wang Lin (L)
Long-Term Outcome of Isolated Duodenal Transit Bipartition as Initial Metabolic Surgery: A 19-Year Follow-Up Case Report.
de Melo Paulo Reis Rizzo Esselin (PRRE);Dib Victor Ramos Mussa (VRM);Madalosso Carlos Augusto Scussel (CAS);d'Almeida Luiz Alfredo Vieira (LAV);de Godoy Eudes Paiva (EP);Chaim Elinton Adami (EA);de Aquino Caio Gustavo Gaspar (CGG);Ribeiro Rui José Silva (RJS);Madalosso Carlos Antonio (CA);Okano Júnior Hiroji (H);Baretta Giorgio Alfredo Pedroso (GAP);Kruel Nicholas Tavares (NT);Waltrick Junior Joe Joaquim (JJ);Kfouri Diogo Swain (DS);Dos Santos Félix Antônio Insaurriaga (FAI);Kawahara Nilton Tokio (NT);Abaid Rafael Antoniazzi (RA);de Barros Fernando (F);Frota Dillenburg Carlos (C);Sampaio Neto José Geraldo Moraes (JGM);da Costa Ricardo Augusto Martins Bueno (RAMB);Goyano Guilherme Spósito Ribeiro (GSR);Melo Fernando Reis Esselin (FRE);Braga Thonya Cruz (TC);Caiña Daniel Oscar (DO);Noel Patrick (P);Yunus Tahir Ebrahim (TE);Parmar Chetan (C);Zorron Ricardo (R);Teixeira André (A);Galvao Neto Manoel (M);Ramos Almino Cardoso (AC);Torres Antônio (A)
Intestinal Energy Absorption is Associated with Post-Bariatric Surgery Weight Loss.
Qian Yunzhi (Y);Sorgen Alicia (A);Steffen Kristine (K);Heinberg Leslie (L);Reed Kylie (K);Malazarte Aliyah (A);Fodor Anthony (A);Carroll Ian (I)
The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease.
Fouad Yasser (Y);Elwakil Reda (R);Sanai Faisal M (FM);Ojo Olusegun (O);Awadhi Sameer Al (SA);Ocama Ponsiano (P);AbdelAty Nadia (N);Al-Busafi Said A (SA);Awuku Yaw Asante (YA);Zaki Samy (S);Abdulla Maheeba (M);Ng'wanasayi Masolwa (M);Said Ebada (E);Altarrah Munira Y (MY);El-Shabrawi Mortada H F (MHF);Ally Reidwan (R);Tahiri Mohamed (M);Bazeed Shamardan (S);Ajlouni Yousef (Y);Gomaa Ahmed Aly (AA);Hamed Abdel-Khalek (AK);Desalegn Hailemichael (H);Derbala Moutaz (M);Kamal Enas (E);Abdo Abdulmunem A (AA);Sabbah Meriam (M);Mehrez Mai (M);Shahat Amal (A);Ndububa Dennis Amajuoyi (DA);Fares Eman (E);Afredj Nawel (N);Mostafa Alaa M (AM);Hashim Almoutaz (A);Eletreby Rasha (R);Farhat Manar Sayed (MS);Ghanem Yahya (Y);Salama Asmaa (A);Debzi Nabil (N);Abdeltawab Doaa (D);Abo-Amer Yousry Esam-Eldin (YE);Nafady Shaymaa (S);Kayamba Violet (V);Zaghloul Mariam (M);Alem Shereen Abdel (SA);Elwazzan Doaa (D);Elwakil Omar (O);Hassani Abdulla Al (AA);Alkhalidi Nawal (N);Sharaf-Eldin Mohamed (M);Ormeci Necati (N);Eslam Mohammed (M)
Improving cardiovascular risk prediction in metabolic liver disease with a novel biomarker-enhanced model.
Hegstrom Lars (L);Kim Yestle (Y);Vu Pete (P);Wagner Tyler (T);Gish Robert (R)
Living liver donor safety: Preoperative aspects of living liver donation guidelines from the ILTS-iLDLT consensus conference.
Selzner Nazia (N);Patel Madhukar S (MS);Khan Mohammad Qasim (MQ);Magistri Paolo (P);Sayed Blayne Amir (BA);Rammohan Ashwin (A);Humar Abhinav (A);Abbey Susan (S);Badenoch Heather (H);Bhangui Pooja (P);Cattral Mark (M);Durand Francois (F);Gross Jed Adam (JA);Hibi Taizo (T);Jhaveri Kartik (K);Kabacam Gokhan (G);Khan Muhammad (M);Malik Ashish (A);Nadalin Silvio (S);Ng Vicky L (VL);Petrowsky Henrik (H);Pillai Anjana (A);Reddy Mettu Srinivas (MS);Tokat Yaman (Y);Wong Tiffany (T);Yilmaz Sezai (S);Yoshizumi Tomoharu (T);Ascher Nancy (N);Broering Dieter (D);Burra Patrizia (P);Chen Chao-Long (CL);Hirschfield Gideon (G);Lerut Jan (J);Mas Valeria (V);Taner Timucin (T);Terrault Norah (N);Vyas Mary P (MP);Wiggins Chantal (C);Heimbach Julie (J);Olthoff Kim (K);Rela Mohamed (M);Bhangui Prashant (P)
The Impact of Body Weight Change on Liver Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Across Various Histological Endpoints: A Systematic Review and Meta-Analysis.
Jayabalan Dujinthan (D);Dhakal Sugam (S);Chandra Jeffrey (J);Fasser Daniel A (DA);Jeffrey Gary P (GP);Garas George (G);Vilar-Gomez Eduardo (E);Calzadilla-Bertot Luis (L);Adams Leon A (LA)
Impact of body mass index on the outcomes of endoscopic retrograde cholangiopancreatography: a systematic review and network meta-analysis.
Arabpour Erfan (E);Khoshdel Sina (S);Looha Mehdi Azizmohammad (MA);Sadeghi Amir (A);Abdehagh Mohammad (M)
Does Metabolic Dysfunction-Associated Steatotic Liver Disease Affect the Ocular Circulation?
Aydın Nihat (N);Capraz Mustafa (M);Akman Burcu (B);Altınok Seyma Nur (SN);Tufek Melek (M);Kara Caner (C)
Empagliflozin and its impact on hepatic and metabolic outcomes in patients with type 2 diabetes and NAFLD: a systematic review and meta-analysis.
Hamzah Khadeeja Ali (KA);Shweliya Mohammedsadeq A (MA);Kurmasha Yousif Hameed (YH);Ahmed Marafi Jammaa (MJ);Habib Ashna (A);Kamel Abanoub I I (AII);Rashid Zarwa (Z);Shimal Aya Ahmed (AA);Moghazy Mayar (M);Fahem Fatima (F);Al Aboud Mohammad Yassin (MY);Elgazzar Ahmed (A);Mahgoub Abdulhadi M A (AMA);Al-Shammari Ali Saad (AS)